Abstract
An estimated 150,000 cases of cardiogenic shock occur each year in the United States. In spite of conventional therapy, which includes emergency revascularization, pharmacologic therapy, and intraaortic balloon pump counter-pulsation, the reported mortality for cardiogenic shock is 80-90% [1-3]. The limited use of left ventricular assist devices (LVADs) in cases of cardiogenic shock has shown a significant potential to decrease mortality [4-11], however, the necessity for a major surgical procedure has confined the use of LVADs to postcardiotomy patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Parmley W. Cardiac failure. In Rosen MR, Hoffman BF, eds. Cardiac Therapy, Martians Nijhoff Publishers, Boston, 1983; pp. 21–44.
Schoen FJ, Palmer DC, Bernhard WF, et al. Clinical temporary ventricular assist. J Thorac Cardiovasc Sur,1986; 92:1071–1081.
Shoemaker WC, Bland RD, Appel PL. Therapy of critically ill postoperative patients based on outcome prediction and prospective clinical trials. Surg OM North Am 1985; 65(4):811–833.
Campbell CD, Tolitano DJ, Weber KT, Sutler PM, Replogle RL.Mechanical support for postcardiotomy heart failure. J Cardiac Surg 1988; 3:181–191.
Golding LR, Jacobs G, Groves LK, Gill CC, Nose’ Y, Loop PD. Clinical results of mechanical support of the failing left ventricle. J Thorac Cardiovasc Sur, 1982; 83:597–601.
Kantrowitz A, Wasfie T, Freed P, Rubenfire M, Wajszczuk W, Schork MA.]ntraaortic balloon pumping 1967 through 1982: Analysis of complications in 733 patients. Am J Cardio! 1986; 57:976–983.
Maccioli GA, Lucas WJ, Norfeet EA. The intraaortic balloon pump: A review. J Cardiothorac Anesth 1988; 2(3):365–373.
McEnany MT, Kay HR, Buckley MR, et al. Clinical experience with intraaortic balloon pump support in 728 patients. Circulation 1978; 58:122–132.
Pae WE, Pierce WS, Pennock JL, Campbell DB, Waldpausen JA. Long-term results of ventricular assist pumping in postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 1987; 93:431–441.
Pennington DG, Samuels LD, Williams G, et al. Experience with the Pierce-Donachy ventricular assist device in postcardiotomy patients with cardiogenic shock. World J Stirs 1985; 9:37–46.
Pennington DG, Swartz M, Codd J, Merjavy J, Kaiser G. Intraaortic balloon pumping in cardiac surgical patients: A nine-year experience. Aun Thorac Surg 1983; 36(2):125–131.
Laas J, Campbell CD, Takanashi Y, Replogle RL. Oxygen consumption of the left ventricle during transapical left ventricular bypass. J Thorar Cardiovasc Surg 1980; 80(2): 280–288.
Lass J, Campbell CD, Takanashi Y, Pick R, Replogle RL. Preservation of ischemic myocardium with TALVB using complete left ventricular decompression. Trans Am Soc Asti(Intern Org 1979; 25:220–223.
Maroko PR, Bernstein EF, Libby P, et al. Effects of intraaortic balloon counterpulsation on the severity of myocardial ischernic injury following acute coronary occlusion. Circulation 1972; 14:1150–1159.
Takanashi Y, Campbell CD, Laas J, Pick RL, Meus P, Replogle RL. Reduction of myocardial infarct size in swine: A comparative study of intraaortic balloon pumping and transapical left ventricular bypass. Aim Thorac Surg 1981; 32(5):475–485.
Bernstein EF, Dorman FD, Blackshear PL, Scott DR. An efficient, compact blood pump for assisted circulation. Surgery 1970; 68(1):105–115.
Farrar DJ, Hill JD, Gray LA, et al. Heterotopic prosthetic ventricles as a bridge to cardiac transplantation. New Eng.) Med 1988; 318:333–340.
Magovern GJ, Park SB, Maher TD. Use of a centrifugal pump without anticoagulants for postoperative left ventricular assist. World J Surg 1985; 9:25–36.
Pae WE, Pierce WS. Combined registry for the clinical use of mechanical ventricular assist pumps and the total artificial heart: Third official report - 1988. J Heart Tramp 1989, in press.
Pennington DG, Merjavy JP, Swartz MT, Willman VL. Clinical experience with a centrifugal pump ventricular assist device. Trans Aen Soc Artif Intern Organs 1982; 28:93–99.
Merhige ME, Smalling RW, Cassidy D, Barrett R, Wise G, Short J, Wampler RK. Effect of the Hemopump left ventricular assist device on regional myocardial perfusion and function: Reduction of ischemia during coronary occlusion. Circulation 1989; 80(Suppl. 111):158–166.
Wampler RK, Moise JC, Frazier OH, Olsen DB. In vivo evaluation of a peripheral vascular access axial flow blood pump. ASAIO Trans 1988; 34:450–454.
Butler KC, Moise JC, Wampler, RK. The Hemopump: A new cardiac prothesis device, IEEE Trans Biomed Engin, in press.
Frazier OH, Duncan JM, Nakatani T, Parnis SM, Fuqua JM. Clinical experience with the Hemopump (abstr). ASAIO 1989; 35:17.
Frazier OH, Wampler RK, Duncan JM, Dear WE, Macris MP, Parnis SM, Fuqua JM. First human use of the Hemopump, a catheter-mounted ventricular assist device. J Am Coll Cardio! 1989; 13(2):121A.
Frazier OH, Macris MP, Wampler RK, Duncan JM, Sweeney MS, Moncrief CL, Fuqua JM. Treatment of cardiac allograft failure by use of an intraaortic axial flow pump. J Heart Transp! 1989; 8:110.
Rutan PM, Rountree WD, Myers KK, Barker LE. Initial experience with the Hemopump. Crit Care Nurs Clin North Am 1989; 1(3):527–534.
Smalling RW, Sweeney MJ, Cassidy DB, Barrett RL, Morris RE, Lammermeier DE, Key PG, Haynie MP, Frazier OH, Wampler RK. Hemodynamics in cardiogenic shock after acute myocardial infarction with the Hemopump assist device. Circulation 1989; 80(4):11–624.
Loisance D, Dubois-Rande JL, Deleuze P, Okude J, Rosenval O, Geschwind H. Prophylactic Ultra ventricular pumping in high risk coronary angioplasty. Lancet 1990; 335(24):438–440.
Norman JC, Cooley DA, Igo SR, et al. Prognostic indices for survival during postcardiotomy intraaortic balloon pumping. J Therse Cardiovasc Surg 1977; 74(5):709–720.
Shawl FA, Dontanski MJ, Hernandez TJ, Punja S. Percutaneous cardiopulmonary bypass support in high risk patients undergoing percutaneous transluminal coronary angioplasty. Ain J Cardio! 1989; 64:1258–1268.
Shawl FA. Percutaneous cardiopulmonary bypass support in high risk interventions. J Iuvas Cardio! 1989; 5:287–291
Bergentz, SE, et al. Incidence of thromboembolism in association with surgical and medical diseases. Acta Chir Scand 1988; 543(Suppl.):10–14.
Chesebro JH, et al. Intracardiac thrombi and systemic thromboembolism; detection, incidence, and treatment. Ann Rev Med 1985; 36:579–605.
Haugland JM, et al. Embolic potential of left ventricular thrombi detected by two-dimensional echocardiography. Circulation 1984; 70(4):588–598.
Okamoto, Buckberg, et al. Studies of controlled reperfusion after ischemia VIII. Regional blood cardioplegic reperfusion during total vented bypass without thoracotomy: A new concept. J Thorn(Cardiovasc Surg 1986; 92:553–563.
Allen, Buckberg, et al. Studies of controlled reperfusion after ischemia XIII. Reperfusion conditions: Critical importance of total ventricular decompression during regional reperfusion. J Thorn(Cardiovasc Surg 1986; 92:605–612.
Smalling RW, Cassidy DB, Merhige M, Felli PR, Wise GM, Barrett RL, Wampler RK. Improved hemodynamic and left ventricular unloading during acute ischemia using the Hemopump left ventricular assist device compared to intraaortic balloon counterpulsation. J Ann Coll Cardiol 1989; 13(2):160A.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wampler, R.K., Riehle, R.A. (1991). Clinical Experience with the Hemopump Left Ventricular Assist Device. In: Shawl, F.A. (eds) Supported Complex and High Risk Coronary Angioplasty. Interventional Cardiology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3890-5_14
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3890-5_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6735-2
Online ISBN: 978-1-4615-3890-5
eBook Packages: Springer Book Archive